Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Walgreens profit beats, Rite Aid deal seen closing in 2017

Published 10/20/2016, 08:43 AM
Updated 10/20/2016, 08:43 AM
© Reuters. The Walgreens store in Times Square seen in New York

By Sruthi Ramakrishnan

(Reuters) - Drugstore operator Walgreens Boots Alliance Inc (O:WBA) reported a better-than-expected quarterly profit, helped by cost cutting, and said it now expected its acquisition of Rite Aid Corp (N:RAD) to close on Jan. 27, three months later than planned.

Walgreens said in September it would likely have to divest between 500 and 1,000 stores to get regulatory clearance for the $9.4 billion deal.

Walgreens, the No. 1 U.S. drugstore operator by store count, had previously said it expected it would need to divest not more than 500 stores and that the deal would close on Oct. 27.

The company said it expected to divest stores to win approval for the deal by the end of 2016.

Supermarket chain Kroger Co (N:KR) is questioning whether to proceed with buying divested stores from Walgreens, a source familiar with the situation said on Wednesday, casting doubts on the future of the Walgreens-Rite Aid deal.

Kroger and Walgreens representatives declined to comment.

Walgreens wants to buy Rite Aid to widen its footprint in the United States and negotiate for lower drug costs.

Walgreens' shares were up 1.7 percent at $78.50 in premarket trading after closing at their lowest in five months on Wednesday. Rite Aid's shares were up about 4.4 percent at $6.95.

"The longer the (merger) process takes the more likely it is to close as it signals a delay in sorting out the divestiture package vs. a true blockage by FTC," Evercore ISI analyst Ross Muken wrote in a client note.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Walgreens said on Thursday its net income attributable to the company rose to $1.03 billion, or 95 cents per share, in the fourth quarter ended Aug. 31, from $26 million, or 2 cents per share, a year earlier.

The company had recorded a loss of $143 million on a previously held equity interest and $479 million in other expenses in the year-ago quarter.

Walgreens said it met its goal of achieving $1 billion in synergies in June from its Boots Alliance acquisition. It is also working on cutting $1.5 billion in costs by the end of its fiscal year ending in August 2017, including by closing about 200 stores and reorganizing operations, among other measures.

Excluding items, the company earned $1.07 per share in the quarter, beating the average analyst estimate of 99 cents per share, according to Thomson Reuters I/B/E/S.

Sales rose marginally to $28.64 billion, missing the average estimate of $29.06 billion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.